Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg and Prednisolone for Unexplained RPL After ART
NCT04701034Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Jan 2021
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G, prednisolone in recurrent pregnancy loss (RPL), sponsored by Aalborg University Hospital. Started Jan 2021; status: completed.
02
Drugs
intravenous immunoglobulin Gprednisolone
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT04701034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04701034.